Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1

Oncology Reports

Volumn 23, Issue 3, 2010, Pages 869-874

  Takacova, Martina ^a   Holotnakova, Tereza ^a   Barathova, Monika ^a   Pastorekova, Silvia ^a   Kopacek, Juraj ^a   Pastorek, Jaromir ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

Carbonic anhydrase IX; Hypoxia; Hypoxia inducible factor; Src

Indexed keywords

CARBONATE DEHYDRATASE IX; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ARTICLE; ENZYME ACTIVITY; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HYPOXIA; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PROMOTER REGIONS, GENETIC; SRC-FAMILY KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77349098742     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000709     Document Type: Article

References (34)

1. Pastorekova S, Parkkila S, Pastorek J and Supuran CT: Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 19: 199-229, 2004.
2. Pastorekova S, Parkkila S and Zavada J: Tumor-associated carbonic anhydrases and their clinical significance. Adv Clin Chem 42: 167-216, 2006.
3. Pastorekova S, Parkkila S, Parkkila AK, et al: Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology 112: 398-408, 1997.
4. Wykoff CC, Beasley NJ, Watson PH, et al: Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60: 7075-7083, 2000.
5. Kaluz S, Kaluzova M, Chrastina A, et al: Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase. Cancer Res 62: 4469-4477, 2002.
6. Kaluz S, Kaluzova M and Stanbridge EJ: The role of extracellular signal-regulated protein kinase in transcriptional regulation of the hypoxia marker carbonic anhydrase IX. J Cell Biochem 97: 207-216, 2006.
7. Kopacek J, Barathova M, Dequiedt F, et al: MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX. Biochim Biophys Acta 1729: 41-49, 2005.
8. Wang GL, Jiang BH, Rue EA and Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
9. Jaakkola P, Mole DR, Tian YM, et al: Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292: 468-472, 2001.
10. Maxwell PH, Wiesener MS, Chang GW, et al: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275, 1999.
11. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML and Bruick RK: FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16: 1466-1471, 2002.
12. Lando D, Peet DJ, Whelan DA, Gorman JJ and Whitelaw ML: Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295: 858-861, 2002.
13. Schofield CJ and Ratcliffe PJ: Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5: 343-354, 2004.
14. Bardos JI and Ashcroft M: Hypoxia-inducible factor-1 and oncogenic signalling. Bioessays 26: 262-269, 2004.
15. Chan DA, Sutphin PD, Denko NC and Giaccia AJ: Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J Biol Chem 277: 40112-40117, 2002.
16. Jiang BH, Agani F, Passaniti A and Semenza GL: V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 57: 5328-5335, 1997.
17. Karni R, Dor Y, Keshet E, Meyuhas O and Levitzki A: Activated pp60c-Src leads to elevated hypoxia-inducible factor (HIF)-1 alpha expression under normoxia. J Biol Chem 277: 42919-42925, 2002.
18. Thomas SM and Brugge JS: Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13: 513-609, 1997.
19. Brown MT and Cooper JA: Regulation, substrates and functions of src. Biochim Biophys Acta 1287: 121-149, 1996.
20. Brugge JS and Erikson RL: Identification of a transformation-specific antigen induced by an avian sarcoma virus. Nature 269: 346-348, 1977.
21. Martin GS: The hunting of the Src. Nat Rev Mol Cell Biol 2: 467-475, 2001.
22. Frame MC: Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 1602: 114-130, 2002.
23. Nada S, Okada M, MacAuley A, Cooper JA and Nakagawa H: Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature 351: 69-72, 1991.
24. Pastorekova S, Zavadova Z, Kostal M, Babusikova O and Zavada J: A novel quasi-viral agent, MaTu, is a two-component system. Virology 187: 620-626, 1992.
25. Holotnakova T, Ziegelhoffer A, Ohradanova A, et al: Induction of carbonic anhydrase IX by hypoxia and chemical disruption of oxygen sensing in rat fibroblasts and cardiomyocytes. Pflugers Arch 456: 323-337, 2008.
26. Kaluz S, Kaluzova M, Opavsky R, et al: Transcriptional regulation of the MN/CA 9 gene coding for the tumor-associated carbonic anhydrase IX. Identification and characterization of a proximal silencer element. J Biol Chem 274: 32588-32595, 1999.
27. Chen C, Pore N, Behrooz A, Ismail-Beigi F and Maity A: Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem 276: 9519-9525, 2001.
28. Seko Y, Tobe K, Takahashi N, Kaburagi Y, Kadowaki T and Yazaki Y: Hypoxia and hypoxia/reoxygenation activate Src family tyrosine kinases and p21ras in cultured rat cardiac myocytes. Biochem Biophys Res Commun 226: 530-535, 1996.
29. Rak J, Mitsuhashi Y, Bayko L, et al: Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 55: 4575-4580, 1995.
30. Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS and Sukhatme VP: Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375: 577-581, 1995.
31. Ellis LM, Staley CA, Liu W, et al: Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src. J Biol Chem 273: 1052-1057, 1998.
32. Gleadle JM and Ratcliffe PJ: Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase. Blood 89: 503-509, 1997.
33. Kaluzova M, Pastorekova S, Svastova E, Pastorek J, Stanbridge EJ and Kaluz S: Characterization of the MN/CA 9 promoter proximal region: a role for specificity protein (SP) and activator protein 1 (AP1) factors. Biochem J 359: 669-677, 2001.
34. Harris KF, Shoji I, Cooper EM, Kumar S, Oda H and Howley PM: Ubiquitin-mediated degradation of active Src tyrosine kinase. Proc Natl Acad Sci USA 96: 13738-13743, 1999.